Clinical potential of proteomics in the diagnosis of ovarian cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sgroi DC, 1999, In vivo gene expression profile analysis of human breast cancer progression. Cancer Res, 59, 5656
Anderson L, 1997, Electmphotesis, 18, 533
Baselga J, 1998, Cancer Res, 58, 2825
Paweletz CP, 2000, Drug Dev Res, 49, 34, 10.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.0.CO;2-W
Paweletz CP Charboneau L, Bichsel VE eta]., 2001, Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene, 20, 1981
Emmert-Buck MR, 2000, Mal Carcinog, 27, 158, 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO;2-2
Banks RE, 1999, Bectivphotesis, 20, 689
Merchant M, 2000, Electrophoresis, 21, 1164, 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0
Friedlander ML, 1998, Semin. Oncol, 25, 305
Trope C, 1998, Sernin. Oncol, 25, 372
Schwartz PE, 1995, Med, 27, 519
McGuire V, 2002, Survival among US women with invasive epithelial ovarian cancer. Gynecol Oncol, 84, 399
van Nagell JR, 1995, Cancer Metastasis Rev, 76, 2086